TABLE 2.
Variable | Total | Participants Who Reported Chronic Pain | Participants Who Did Not Report Chronic Pain |
---|---|---|---|
N | 13884 | 2168 | 11716 |
Age, mean (sd) | 50.9 (19.6) | 53.3 (17.7) | 50.4 (20.0) |
Male, N (%) | 6579 (47) | 922 (43) | 5657 (48) |
Race/ethnicity, N (%) | |||
Non-Hispanic White | 6951 (50) | 1274 (59) | 5677 (48) |
Non-Hispanic Black | 2654 (19) | 393 (18) | 2261 (19) |
Mexican American | 3112 (22) | 333 (15) | 2779 (24) |
Other Race | 1167 (8) | 168 (8) | 999 (9) |
Education years, N (%) | |||
<9th grade | 2287 (17) | 316 (15) | 1971 (17) |
9–11 grade | 2356 (17) | 401 (19) | 1955 (17) |
High school graduate | 3296 (24) | 561 (26) | 2735 (23) |
College degree or above | 5889 (43) | 882 (41) | 5007 (43) |
Poverty income ratio, mean (sd) | 2.6 (1.6) | 2.4 (1.6) | 2.6 (1.6) |
Health insurance coverage, N (%) | 11038 (81) | 1774 (83) | 9264 (80) |
Marital status (married), N (%) | 7425 (56) | 1142 (54) | 6283 (56) |
Smoking, N (%) | 6655 (48) | 1270 (59) | 5385 (46) |
Alcohol, N (%) | 7937 (57) | 1303 (60) | 6634 (57) |
Anti-depressant medication prescription, N (%) | 1038 (7) | 372 (17) | 666 (6) |
Illicit drug usea, N (%) | 1419 (16) | 299 (23) | 1120 (15) |
Comorbidities, N (%) | |||
Coronary heart diseases | 639 (5) | 184 (9) | 455 (4) |
Cancer | 1247 (9) | 283 (13) | 964 (8) |
Arthritis | 2375 (17) | 735 (34) | 1640 (14) |
Opioid prescriptions, N(%) | |||
Total opioidsb | 683 (5) | 382 (18) | 301 (3) |
Opioids equivalent to or stronger than morphinec | 360 (3) | 223 (10) | 137 (1) |
Illicit drug use was only asked for participants aged 20–59 years (N = 8630).
Total opioids included codeine, dihydrocodeine, meperidine, pentazocine, propoxyphene, tramadol, hydrocodone, morphine, tapentadol, fentanyl, hydromorphone, methadone, oxycodone, and oxymorphone.
Opioids equivalent to or stronger than morphine included hydrocodone, morphine, tapentadol, fentanyl, hydromorphone, methadone, oxycodone, and oxymorphone.